Background: MRI assessment in multiple sclerosis (MS) focuses on the presence of typical white matter (WM) lesions. Neurodegeneration characterised by brain atrophy is recognised in the research field as an important prognostic factor. It is not routinely reported clinically, in part due to difficulty in achieving reproducible measurements. Automated MRI quantification of WM lesions and brain volume could provide important clinical monitoring data. In general, lesion quantification relies on both T1 and FLAIR input images, while tissue volumetry relies on T1. However, T1-weighted scans are not routinely included in the clinical MS protocol, limiting the utility of automated quantification. Objectives: We address an aspect of this impor...
ABSTRACT BACKGROUND AND PURPOSE A pipeline for fully automated segmentation of 3T brain MRI scans in...
Background and rationale: Thalamus atrophy has been linked to cognitive decline in multiple scleros...
BACKGROUND: Methodological challenges limit the use of brain atrophy and lesion burden measures in t...
Background: MRI assessment in multiple sclerosis (MS) focuses on the presence of typical white matt...
Introduction Magnetic resonance imaging (MRI) has become key in the diagnosis and disease monitoring...
Background and Purpose: VBM has been widely used to study GM atrophy in MS. MS lesions lead to segme...
Nowadays magnetic resonance imaging is used for anatomical assessment of human brain structures in n...
Jain S., Sima D.M., Ribbens A., Cambron M., Maertens A., Van Hecke W., De Mey J., Barkhof F., Steenw...
Deep grey matter (DGM) atrophy in multiple sclerosis (MS) and its relation to cognitive and clinical...
Background: Although quantitative measures from research-quality MRI provide a means to study multip...
PURPOSE: Volume measurement using MRI is important to assess brain atrophy in multiple sclerosis (MS...
White-matter lesion count and volume estimation are key to the diagnosis and monitoring of multiple ...
OBJECTIVE: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large popu...
peer reviewedDespite robust postmortem evidence and potential clinical importance of gray matter (GM...
The presence of cortical lesions in multiple sclerosis patients has emerged as an important biomarke...
ABSTRACT BACKGROUND AND PURPOSE A pipeline for fully automated segmentation of 3T brain MRI scans in...
Background and rationale: Thalamus atrophy has been linked to cognitive decline in multiple scleros...
BACKGROUND: Methodological challenges limit the use of brain atrophy and lesion burden measures in t...
Background: MRI assessment in multiple sclerosis (MS) focuses on the presence of typical white matt...
Introduction Magnetic resonance imaging (MRI) has become key in the diagnosis and disease monitoring...
Background and Purpose: VBM has been widely used to study GM atrophy in MS. MS lesions lead to segme...
Nowadays magnetic resonance imaging is used for anatomical assessment of human brain structures in n...
Jain S., Sima D.M., Ribbens A., Cambron M., Maertens A., Van Hecke W., De Mey J., Barkhof F., Steenw...
Deep grey matter (DGM) atrophy in multiple sclerosis (MS) and its relation to cognitive and clinical...
Background: Although quantitative measures from research-quality MRI provide a means to study multip...
PURPOSE: Volume measurement using MRI is important to assess brain atrophy in multiple sclerosis (MS...
White-matter lesion count and volume estimation are key to the diagnosis and monitoring of multiple ...
OBJECTIVE: To measure white matter (WM) and gray matter (GM) atrophy and lesion load in a large popu...
peer reviewedDespite robust postmortem evidence and potential clinical importance of gray matter (GM...
The presence of cortical lesions in multiple sclerosis patients has emerged as an important biomarke...
ABSTRACT BACKGROUND AND PURPOSE A pipeline for fully automated segmentation of 3T brain MRI scans in...
Background and rationale: Thalamus atrophy has been linked to cognitive decline in multiple scleros...
BACKGROUND: Methodological challenges limit the use of brain atrophy and lesion burden measures in t...